Multidrug resistance (MDR) in cancer

This publication has 162 references indexed in Scilit:

• Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
  Seminars in Cancer Biology, 1997
• Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells
  European Journal Of Cancer, 1995
• Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
  Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
• The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug Resistance
  Biochemical and Biophysical Research Communications, 1995
• Differential inhibition by cyclosporins of primary‐active ATP‐dependent transporters in the hepatocyte canalicular membrane
  FEBS Letters, 1993
• p53 is required for radiation-induced apoptosis in mouse thymocytes
  Nature, 1993
• P‐glycoprotein and alterations in the glutathione/glutathione‐peroxidase cycle underlie doxorubicin resistance in HL‐60‐R, a subclone of the HL‐60 human leukemia cell line
  International Journal of Cancer, 1993
• Reversal of multi‐drug resistance in human KB cell lines by structural analogs of verapamil
  International Journal of Cancer, 1990
• Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of Doxorubicin (Adriamycin) in resistant P388 mouse leukemia cells
  European Journal of Cancer and Clinical Oncology, 1984
• Comparison of nitrogen-mustard-sensitive and -resistant yoshida sarcomas
  International Journal of Cancer, 1966